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Background: With quantitative sensory testing (QST) we recently found no differences in sensory function of the
foot soles between groups of torture victims with or without exposure to falanga (beatings under the feet).
Compared to matched controls the torture victims had hyperalgesia to deep mechano-nociceptive stimuli and
hypoesthesia to non-noxious cutaneous stimuli. The purpose of the present paper was to extend the group analysis
into individual sensory profiles of victims’ feet to explore possible relations between external violence (torture),
reported pain, sensory symptoms and QST data to help clarify the underlying mechanisms.
Methods: We employed interviews and assessments of the pain and sensory symptoms and QST by investigators
blinded to whether the patients, 32 male torture victims from the Middle East, had (n=15), or had not (n=17) been
exposed to falanga. Pain intensity, area and stimulus dependence were used to characterize the pain. QST included
thresholds for touch, cold, warmth, cold-pain, heat-pain, deep pressure pain and wind-up to cutaneous noxious
stimuli. An ethnically matched control group was available.The normality criterion, from our control group data, was
set as the mean +/− 1.28SD, thus including 80% of all values.QST data were transformed into three categories in
relation to our normality range; hypoesthesia, normoesthesia or hyperesthesia/hyperalgesia.
Results: Most patients, irrespective of having been exposed to falanga or not, reported severe pain when walking.
This was often associated with hyperalgesia to deep mechanical pressure. Hypoesthesia to mechanical stimuli
co-occurred with numbness, burning and with deep mechanical hyperalgesia more often than not, but otherwise, a
hypoesthesia to cutaneous sensory modalities did not co-occur systematically to falanga, pain or sensory
symptoms.
Conclusion: In torture victims, there seem to be overriding mechanisms, manifested by hyperalgesia to pressure
pain, which is usually considered a sign of centralization. In addition there was cutaneous hypoesthesia, but since
there was no obvious correlation to the localization of trauma, these findings may indicate centrally evoked
disturbances in sensory transmission, that is, central inhibition. We interpret these findings as a sign of changes in
central sensory processing as the unifying pathological mechanism of chronic pain in these persons.
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Many victims of torture, even after extended time peri-
ods, experience pain in the feet when walking. The use
of falanga (beatings on the soles of the feet) is a torture
method which deliberately aims at inflicting intense pain
in the feet and lower legs [1,2]. It is nowadays used sys-
tematically as a torture method especially in the Middle
East and the Far East [3]. The foot pain often persists
years after torture [2,4,5], and contributes to severe dis-
abilities [6], even when walking moderate distances.
In previous studies we have confirmed and extended
the clinical evidence of chronic foot pain and disability
in falanga victims with chronic pain in the feet [5,6].
Chronic pain is also common after generalized torture.
Olsen at al. [7] found that more than 80% of patients re-
ferred for rehabilitation of torture sequaele reported
chronic pain. Similar figures have been reported for war
veterans with post-traumatic stress disorders (PTSD;[8]).
In addition, Defrin et al. [9] recently found that persons
with PTSD may exhibit altered sensory processing.
When examining torture victims with quantitative sen-
sory testing (QST), we recently and remarkably found no
obvious differences in sensory function of the foot soles
between groups of torture victims with or without expo-
sure to falanga [10]. This was so in spite of the fact that al-
most all the falanga victims had moderate to strong pain
in their feet and in twice as large an area of their foot soles
as those torture victims who had not been exposed to
falanga. One third of the latter did not report pain in their
feet at all and many reported only slight pain. On the
other hand, when compared to matched controls, torture
victims had hyperalgesia to deep mechano-nociceptive
stimuli, irrespective of exposure to falanga or to other
forms of torture. Furthermore, cutaneous sensory fibre
groups except those transmitting cold and heat pain see-
med to be less sensitive to external stimuli. These findings
are compatible with central changes of sensory transmis-
sion [11]. Thus, there seems to be a blend of chronic pain
conditions in the feet of torture victims so that analyses of
means at the group level do not reveal significant differ-
ences; thus the data should be analysed individually.
The primary objective of the present paper was to ex-
tend the group analysis of the QST data from our previ-
ous study [10] into individual sensory profiles of victims’
feet to explore possible relations between external violence
(torture), reported pain, sensory symptoms and QST data
to help clarify the underlying pain mechanisms [5,12].
Methods
Participants
The patients recruited were torture victims who had
been granted asylum in Denmark. They were all referred
to our centre from their general practitioner, because of
their long-term sequelae from various types of torturethat they had been subjected to several years earlier in
their homeland. The patients were screened by an as-
sessment team (physician, psychologist, physiotherapist
and social worker), supported by an interpreter, with refe-
rence to the centre’s admission criteria: 1) torture victim
with asylum in Denmark; 2) physical, psychological and
social needs; 3) no overt psychosis; 4) no drug or alcohol
abuse; and 5) available treatment capacity.
Study selection criteria
The inclusion criteria for this study were tortured male
patients originating from the Middle East and speaking
Arabic or Farsi (the majority of currently referred male pa-
tients during the period May 2009 – June 2010). Seventy-
nine consecutively referred patients were identified via the
electronic patient records (see Flowchart, in [10]). One se-
nior physician (BHS) screened these medical records ac-
cording to the exclusion criteria: pathological structural
changes in the feet and lower legs from reasons other than
falanga, for example, sustained fractures, amputations, ex-
tensive scar tissue after burning or cuttings or foreign
objects embedded in the feet such as shrapnel or bullets;
nerve lesions in the lower legs from causes other than
falanga, for example, diabetic or alcoholic polyneuropathy
and also injury to the central nervous system such as
stroke or spinal fractures. Twenty-seven persons were ex-
cluded, usually due to injury to the nervous system other
than from falanga.
The reasons for exclusions were: rhizopathy (n=7), dia-
betes (n=3), not mentally fit (n=2), opioid medication
(n=2), spinal fracture (n=1), arteriosclerosis in the legs
(n=1), hydrocephalus (n=1), not been tortured but re-
ferred for having been secondarily traumatized (n=3),
other problems and were referred for treatment else-
where (n=7). Clinical symptoms and signs, including the
typical temporal and anatomical progression of sensory
symptoms of peripheral neuropathy were always sought
for during the clinical history–taking and examination.
The remaining 52 patients were invited to participate
in the study. At individual meetings the examiner (KP)
informed them about the purpose and methods used in
the study; seventeen persons turned down the offer at
this stage. If the patient agreed to participate an infor-
med consent form was signed and dates for the assess-
ments arranged. Three persons started but dropped out
during the test sessions. Thus 32 patients participated in
all three sessions. All were offered compensation for
travel expenses. Arabic or Farsi interpreters assisted at
all sessions. The project was carefully introduced to the
three interpreters involved, all of whom had long experi-
ence in interpreting for torture victims.
It was possible to recruit 14 ethnically and age matched
men from the Middle East community in Copenhagen to
form a control group, going through exactly the same
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37 years (range 21–55), had no chronic pain conditions,
and were integrated and active in the Danish society. They
had lived in Denmark for an average of 15.8 years (range
7–26) and all spoke Danish.
Design
The examiner (KP) and a research assistant were blinded
with regard to patient history, diagnosis and whether
falanga torture had occurred or not. Breaking of the blind-
ing took place only after the completion of all examina-
tions and data analyses of the individual patients.
Procedure and measurements
All examinations were scheduled to 3x2 hour sessions
within a two-week period and took place in a quiet room
(stable temperature of 22–24°C) in the research depart-
ment at our centre. For details of the procedures and
measurement techniques, we refer the reader to our pre-
vious paper [10].
Test sites
To our knowledge only few studies have examined the
arch of the foot sole with respect to normal QST values,
and the available data are mostly found from the dor-
sum of the foot [13,14]. According to current standards
for QST, measurements in neuropathic pain conditions
should be performed in the area with the maximum pain
[15] and we therefore chose the arch of the footsole
under the intermediate cuneiform bone bilaterally for all
sensory tests. In addition, this site has been reported to
be the most sensitive in the foot sole [16].
Assessments
Interview
The patients were asked about pain in the foot soles at
rest and when walking and the findings were registered on
a 3-point Likert scale (0=no pain, 1=slight/moderate pain,
and 2=severe pain; cf. [5]) to determine activity related
changes in foot pain. From these data the victims’ feet
could be divided into three groups: no foot pain; stimulus-
independent foot pain (pain appearing spontaneously at
rest); and stimulus-evoked foot pain (pain evoked by acti-
vity, such as walking [5]). Reported sensory disturbances
such as numbness, cold/burning, pricking or buzzing sen-
sation were also registered.
Pain drawings
The patients shaded in the locations of their pain on a
special foot chart (views of right and left foot soles;[17]).
The shaded-in areas on the pain drawings were mea-
sured in square millimetres and calculated in percent of
the total area using a commercial software programme
(Quantify One; K:L:O:N:K, Denmark; [18]).Pain intensity
Self-reported current pain intensity was assessed on a
visual analogue scale (VAS; 0–100 mm; no pain=0; worst
imaginable pain=100; [19]), with reference to each foot
sole separately.
Quantitative sensory testing in the feet
For a detailed description of the techniques used to
measure the different modalities, see our previous study
[10]. Briefly, we measured mechanical detection thresh-
olds (MDT) utilizing Semmes Weinstein monofilaments;
cold detection thresholds (CDT) and warm detection
thresholds (WDT), and also cold pain thresholds (CPT)
and heat pain thresholds (HPT) utilising a thermal stimu-
lator (MEDOC Inc., Israel); and deep mechano-nocicep-
tive thresholds (pressure pain thresholds: PTT) using an
electronic pressure algometer (Somedic, Höör, Sweden).
In addition, temporal summation of mechano-nociceptive
stimuli (wind-up pain) was examined by using the thickest
Semmes-Weinstein monofilament (size 6.65;[20]). At 0.3
Hz the examiner applied the filament four consecutive
times to the surface of the skin in the arch of each foot
sole. The patients were asked to rate the pain intensity
on a VAS after the 1st and 4th stimulus. A 5-minute
pause followed. Thereafter, to produce a more intense
stimulation, 10 consecutive stimuli were applied at the
rate of 1.0 Hz. The patient rated their pain after the
1st and 10th stimulus. If the VAS difference between the
1st and last stimulus was positive, a temporal summa-
tion (wind-up) had occurred.
Dynamic mechanical allodynia is a painful or unpleas-
ant sensation evoked by a cutaneous mechanical stimu-
lus which does not normally evoke pain. To examine
this phenomenon we used light strokes with a soft brush
(SENSELab™– Brush-05; Somedic, Hörby, Sweden).
Three consecutive strokes over a 60 mm long distance
in the arch of both foot soles were applied with the
brush [21], and the patient indicated if the stimulus was
unpleasant or painful.
Some of the QST stimuli that may evoke a transient
unpleasant sensation or pain were applied as a pre-test
in another area far from the feet (the right and left fore-
arm [PPT], or in the palm of the hand [Windup-test]) to
familiarize the patients with the procedures. It was
emphasized that the QST test was not an endurance test
and should not evoke pain; the patients should press the
stop button or indicate to the examiner at the absolute
first instance of pain detection. In this way the patient
was in control at all times.
Statistics
We chose to analyse the data from the right and left feet
separately, since they may share common analysis me-
chanisms in the central nervous system, even if separate.
Table 1 Reported pain, sensory symptoms, pain at rest, pain when walking and type of foot pain sorted by ‘pain when walking’ in the left foot sole of 32
torture victims (blank space=normal)
Patient
code
Falanga and Numbness Cold
sensation
Burning
sensation
Pricking or
buzzing sensation
Dysaesthesia Allodynia Pain at rest Pain when
walking
Type of
foot painNo Falanga
301 Falanga yes yes . yes yes . slight/moderate severe evoked pain
302 Falanga . yes yes yes yes yes slight/moderate severe evoked pain
303 Falanga . . yes . yes . no severe evoked pain
304 No Falanga yes yes yes . . . slight/moderate severe evoked pain
306 No Falanga yes . yes . yes . slight/moderate severe evoked pain
307 No Falanga yes yes yes yes . . slight/moderate severe evoked pain
308 No Falanga yes yes yes yes . . no severe evoked pain
309 Falanga . . yes yes . . slight/moderate severe evoked pain
311 Falanga . yes yes . . . no severe evoked pain
312 Falanga . . . . . . no severe evoked pain
313 No Falanga . . . yes yes yes slight/moderate severe evoked pain
314 No Falanga yes yes yes yes yes . slight/moderate severe evoked pain
316 Falanga yes . yes yes yes . slight/moderate severe evoked pain
317 No Falanga yes yes yes yes yes . severe severe independent pain
322 Falanga . . yes yes . . slight/moderate severe evoked pain
324 Falanga yes . . . yes . slight/moderate severe evoked pain
326 No Falanga yes yes yes yes yes . slight/moderate severe evoked pain
327 Falanga yes . yes yes yes . slight/moderate severe evoked pain
328 Falanga yes yes yes yes . . slight/moderate severe evoked pain
332 No Falanga . yes . yes . . slight/moderate severe evoked pain
333 No Falanga yes . yes yes yes . severe severe independent pain
337 Falanga yes yes yes yes yes . slight/moderate severe evoked pain
338 Falanga yes . yes yes . . slight/moderate severe evoked pain
339 Falanga yes yes yes yes . . severe severe independent pain
310 No Falanga yes . . . yes yes no slight/moderate evoked pain
319 Falanga . . . . . . slight/moderate slight/moderate independent pain
330 No Falanga yes . yes yes yes . no slight/moderate evoked pain
315 No Falanga yes yes yes . . . no no no pain
323 No Falanga . yes . . . . no no no pain
325 No Falanga . . . . . . no no no pain
334 No Falanga . . . . . . no no no pain
335 No Falanga . . . . . . no no no pain
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for all eight QST variables. The data were analyzed using
the Statistical Package for Social Sciences (SPSS) version
18, Software for Windows (SPSS, Chicago; IL; USA).
Ethics
Each participant was informed verbally about the study
and was also given an information kit containing a com-
prehensive written description translated into their respec-
tive languages. They also received translated guidelines
concerning participation in medical research issued by the
Danish Ethical Committee. The assessments comply withTable 2 Categorized sensory functions from QST data (hypo,
intensity and pain area sorted by ‘pain when walking’ in the
Patient code MDT CDT WDT CPT HPT
301 Hypo . . . .
302 Hypo . . Hypo .
303 Hypo . . . .
304 Hypo Hypo Hypo Hypo .
306 Hypo Hypo . . .
307 Hypo Missing Missing Missing Missing
308 Hypo Hypo Hypo Hypo .
309 Hypo . Hypo . .
311 . . . . .
312 Hypo . . . .
313 Hypo Hypo . . .
314 Hypo Hypo Hypo Hypo .
316 . . . . .
317 Hypo . Hypo . .
322 . . . HYPER .
324 Hypo Hypo Hypo Hypo .
326 . . . . .
327 . . . HYPER HYPER
328 Hypo . Hypo . .
332 . Hypo . Missing Missing
333 Hypo Hypo Hypo Hypo .
337 Hypo Hypo Hypo . .
338 Hypo Hypo Hypo . .
339 Hypo Hypo . . .
310 . Hypo Hypo Hypo .
319 . Hypo HYPER . HYPER
330 Hypo Hypo Hypo . .
315 Hypo Hypo Hypo Hypo .
323 . Hypo Hypo . .
325 . . . . .
334 Hypo . . HYPER .
335 Hypo . . . .the Helsinki II Declaration [22] and the patients could
withdraw from the study at any time, without any impact
on their planned rehabilitation at our clinic. The study
was approved by the Research Ethics Committee in Region
Copenhagen, Denmark (H-D-2009-068) and registered in
the Danish Data Protection Agency.
Results
General
All 32 patients reported pain in many parts of the body.
When asked about their one most painful region, neck,
shoulder and low-back pain were the most commonnormal=blank space, HYPER; see text), current pain
left foot sole of 32 torture victims (see Table 1)
PPT Wind-up 0.3 Hz Wind-up 1.0 Hz VAS Pain area
HYPER . . . 56
HYPER HYPER HYPER 95 52
HYPER . . 0 46
. Hypo . 52 58
HYPER . . 15 22
HYPER . . 33 33
HYPER Hypo . 29 1
HYPER . Missing 34 53
. . . 0 0
. . . 0 6
HYPER . . 30 19
. . . 46 14
. . . 50 36
HYPER . . 47 34
HYPER Missing Missing 53 47
. Hypo . 89 89
HYPER . . 100 3
HYPER . HYPER 65 70
HYPER . . 47 74
HYPER Missing Missing 47 65
Hypo Hypo . 37 47
. Hypo . 59 40
. Hypo . 10 88
. Hypo . 82 19
HYPER . . 0 35
HYPER Hypo . 10 28
HYPER Hypo . 20 36
HYPER . . 0 0
. . . 0 0
. . . 0 0
HYPER Hypo . 0 0
HYPER Hypo . 0 0
Table 3 Reported pain, sensory symptoms, pain at rest, pain when walking and type of foot pain sorted by ‘PPT, pain when walking and type of foot pain’ in
the left foot sole of 32 torture victims (blank space=normal) (see Table 4)
Patient
code
Falanga and Numbness Cold
sensation
Burning
sensation
Pricking or
buzzing sensation
Dysaesthesia Allodynia Pain at rest Pain when
walking
Type
No Falanga
306 No Falanga yes . yes . yes . slight/moderate severe evoked pain
307 No Falanga yes yes yes yes . . slight/moderate severe evoked pain
308 No Falanga yes yes yes yes . . no severe evoked pain
313 No Falanga . . . yes yes yes slight/moderate severe evoked pain
326 No Falanga yes yes yes yes yes . slight/moderate severe evoked pain
332 No Falanga . yes . yes . . slight/moderate severe evoked pain
301 Falanga yes yes . yes yes . slight/moderate severe evoked pain
302 Falanga . yes yes yes yes yes slight/moderate severe evoked pain
303 Falanga . . yes . yes . no severe evoked pain
309 Falanga . . yes yes . . slight/moderate severe evoked pain
322 Falanga . . yes yes . . slight/moderate severe evoked pain
327 Falanga yes . yes yes yes . slight/moderate severe evoked pain
328 Falanga yes yes yes yes . . slight/moderate severe evoked pain
317 No Falanga yes yes yes yes yes . severe severe independent pain
310 No Falanga yes . . . yes yes no slight/moderate evoked pain
330 No Falanga yes . yes yes yes . no slight/moderate evoked pain
319 Falanga . . . . . . slight/moderate slight/moderate independent pain
315 No Falanga yes yes yes . . . no no no pain
334 No Falanga . . . . . . no no no pain
335 No Falanga . . . . . . no no no pain
304 No Falanga yes yes yes . . . slight/moderate severe evoked pain
314 No Falanga yes yes yes yes yes . slight/moderate severe evoked pain
311 Falanga . yes yes . . . no severe evoked pain
312 Falanga . . . . . . no severe evoked pain
316 Falanga yes . yes yes yes . slight/moderate severe evoked pain
324 Falanga yes . . . yes . slight/moderate severe evoked pain
337 Falanga yes yes yes yes yes . slight/moderate severe evoked pain
338 Falanga yes . yes yes . . slight/moderate severe evoked pain
339 Falanga yes yes yes yes . . severe severe independent pain
323 No Falanga . yes . . . . no no no pain
325 No Falanga . . . . . . no no no pain
333 No Falanga yes . yes yes yes . severe severe independent pain
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posed to falanga reported their pain as being most severe
in the feet. Data of reported pain and sensory symptoms
for all individuals are presented separately in Tables 1, 2,
3 and 4. We have chosen to present individual data from
the left feet in this paper, since we have previously demon-
strated that there is no marked difference between the
two sides [10].
Normality criterion
Since the results from measuring sensory modalities
with QST have varying denominations, we have chosenTable 4 Categorized sensory function from QST data (hypo, no
and pain area sorted by ‘PPT, pain when walking and type of f
Patient code MDT CDT WDT CPT HPT
306 Hypo Hypo . . .
307 Hypo Missing Missing Missing Missing
308 Hypo Hypo Hypo Hypo .
313 Hypo Hypo . . .
326 . . . . .
332 . Hypo . Missing Missing
301 Hypo . . . .
302 Hypo . . Hypo .
303 Hypo . . . .
309 Hypo . Hypo . .
322 . . . HYPER .
327 . . . HYPER HYPER
328 Hypo . Hypo . .
317 Hypo . Hypo . .
310 . Hypo Hypo Hypo .
330 Hypo Hypo Hypo . .
319 . Hypo HYPER . HYPER
315 Hypo Hypo Hypo Hypo .
334 Hypo . . HYPER .
335 Hypo . . . .
304 Hypo Hypo Hypo Hypo .
314 Hypo Hypo Hypo Hypo .
311 . . . . .
312 Hypo . . . .
316 . . . . .
324 Hypo Hypo Hypo Hypo .
337 Hypo Hypo Hypo . .
338 Hypo Hypo Hypo . .
339 Hypo Hypo . . .
323 . Hypo Hypo . .
325 . . . . .
333 Hypo Hypo Hypo Hypo .to transform the data into three categories in relation to
our matched controls: hypoesthesia, normoesthesia and
hyperesthesia/hyperalgesia (Tables 2 and 4). The norma-
lity values were derived from our control group data
[10], setting normality as the mean +/− 1.28SD, thus in-
cluding 80% of all values. In fact, this criterion produced
normality data (see ranges in Table 5) quite close to
those in the literature. Thus, Bell-Krotoski et al. [23] and
Jeng et al. [16], found the normal values for MDT of the
foot sole to correspond to a mean filament size of 3.61
and 3.57 respectively, equal to a target force of 0.4 g. As
regards thermal thresholds the normal values for feet arermal=blank space, HYPER; see text), current pain intensity
oot pain’ in the left foot sole of 32 torture victims
PPT Wind-up 0.3 Hz Wind-up 1.0 Hz VAS Pain area
HYPER . . 15 22
HYPER . . 33 33
HYPER Hypo . 29 1
HYPER . . 30 19
HYPER . . 100 3
HYPER Missing Missing 47 65
HYPER . . . 56
HYPER HYPER HYPER 95 52
HYPER . . 0 46
HYPER . Missing 34 53
HYPER Missing Missing 53 47
HYPER . HYPER 65 70
HYPER . . 47 74
HYPER . . 47 34
HYPER . . 0 35
HYPER Hypo . 20 36
HYPER Hypo . 10 28
HYPER . . 0 0
HYPER Hypo . 0 0
HYPER Hypo . 0 0
. Hypo . 52 58
. . . 46 14
. . . 0 0
. . . 0 6
. . . 50 36
. Hypo . 89 89
. Hypo . 59 40
. Hypo . 10 88
. Hypo . 82 19
. . . 0 0
. . . 0 0
Hypo Hypo . 37 47
Table 5 Sensory functions in the left foot of 14 healthy controls (mean, SD, 95% CI, median and range for eight QST
variables) and our calculated normality criteria (see text)
MDT target
force g
CDT °C WDT °C` CPT °C HPT °C PPT kPa Wind-up mm
at 0.3 Hz
Wind-up mm
at 1.0 Hz
Mean Mean Mean Mean Mean Mean Mean Mean
SD SD SD SD SD SD SD SD
CI CI CI CI CI CI CI CI
Median Median Median Median Median Median Median Median
(Range) (Range) (Range) (Range) (Range) (Range) (Range) (Range)
Controls n=14 (left foot) 0.33 28.0 40.9 21.1 47.0 456 17 27
0.34 2.4 3.1 4.7 2.5 167 13 22
0.14 – 0.53 26.6 – 29.3 39.1 – 42.7 18.3 – 23.8 45.5 – 48.4 359 – 552 10 – 24 14 – 39
0.16 28.9 41.3 20.6 47.6 461 18 26
(0.07 – 1.00) (21.6 – 30.2) (36.1 – 45.1) (9.2 – 27.9) (42.0 – 49.8) (208 – 783) (0 – 39) (−2 – 63)
Normality criterion range 0 - 0.76 24.9 – 31.1 36.9 – 44.9 15.1 – 27.1 43.8 – 50.0 242 – 670 1 – 34 0 – 55
MDT, mechanical detection threshold; g, gram; CDT, cold detection threshold; WDT, warm detection threshold; CPT, cold pain threshold; HPT, heat pain threshold;
PPT, pressure pain threshold; kPa, kiloPascal; Wind-up mm at 0.3 Hz (mean pre/post difference in pain intensity VAS mm after wind-up stimulation at 0.3 Hz);
Wind-up mm at 1.0 Hz (mean pre/post difference in pain intensity VAS mm after wind-up stimulation at 1.0 Hz).
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from the studies of Yarnitsky et al. [24], Hagander et al.
[13] and Rolke et al. [14]. For CDT the mean thresholds
were 29.5°C, 31.4°C and 30.3°C, respectively. Normal mean
values in the literature for HPT in the feet are (45.5°C:
Yarnitsky et al. [25]; 43.7°C: Hagander et al. [13]; 47.0°C:
Rolke et al. [14]). With mechano-nociceptive stimulation,
Messing et al. [26] found a mean PPT of 344 kPa in the
arch of the foot, whereas Rolke et al. [14] found a mean
PPT of 572 kPa in the dorsum of the foot. The wind-up ef-
fect elicited with 0.3 Hz stimuli was 15 mm in normal sub-
jects (Defrin et al. [9]).
Sensory profiles of pain, symptoms and QST data in
the feet
Since torture victims often present with walking difficul-
ties, we chose to sort our patients according to how in-
tense the reported pain in their feet was when walking
(severe, slight/moderate or none; Tables 1 and 2). In the
following text, all patient findings are represented by the
left foot.
As can be seen in Table 1, most of our patients, ir-
respective of exposure to falanga, reported severe pain
when walking. Such severe pain was often accompanied
by sensory symptoms like burning or pricking and some-
times with dysesthesia also at rest. In Table 2 it can be
seen that severe pain when walking was often associated
with hyperalgesia to deep mechanical pressure (PPT) but
only occasionally to current high pain intensity at rest
(VAS). Hypoesthesia to mechanical stimuli (MDT) co-
occurred with numbness and burning and with deep
mechanical hyperalgesia (PPT) more often than not, but
otherwise, a hypoesthesia to cutaneous sensory modalities
did not co-occur systematically to foot trauma (falanga),pain or sensory symptoms (Tables 1 and 2). Moreover, an
exaggerated wind-up reaction was rare in these patients.
Re-arrangement of data to deepen analysis
A further analysis, re-arranging the data according to:
1) the occurrence of deep hyperalgesia, 2) pain when
walking and 3) type of foot pain, more clearly illustrates
that this change of sensory transmission was as common
after generalized torture as after falanga (Tables 3 and
4). Furthermore, out of the 20 patients with hyperalgesia
to deep mechanical pressure only one patient did not
have any form of cutaneous hypoesthesia. Regarding the
relation to foot trauma 10/15 falanga victims and 12/17
victims of generalized torture had cutaneous mechanical
hypoesthesia (MDT). Moreover, hypoesthesia to mechan-
ical detection was associated with hypoesthesia to cold de-
tection in 12/22 cases and with warm- and cold-detection
hypoesthesia in 9/22 cases. These differences were not sig-
nificant (Fisher’s test).
Discussion
Pain in torture victims
From the present analysis it appears that little discrimi-
nates pain mechanisms in torture victims who have been
exposed to trauma from torture on different parts of the
body. Rather, it seems as if there are important overriding
mechanisms, manifested by the hyperalgesia to pressure
pain in the QST analysis, which is usually considered a
sign of centralization [27] and is also present in fibromyal-
gia and whiplash associated disorders [28,29]. In addition
there were frequently signs of cutaneous hypoesthesia, but
since there was no obvious correlation to the locali-
zation of trauma, it may be speculated that these fin-
dings also indicate centrally evoked disturbances in sensory
Prip et al. BMC International Health and Human Rights 2012, 12:40 Page 9 of 10
http://www.biomedcentral.com/1472-698X/12/40transmission, that is, central inhibition [11]. In fact, other
researchers found, in a large study of Complex Regional
Pain Syndromes, that a combination of sensory loss and
deep mechanical hyperalgesia was present in the majority
of the patients (66 -69%; [11]). Like in their study, the large
inter-individual variation of our QST findings makes
it important to present data individually rather than as
group means.
Regarding torture victims, our findings are on one hand
similar to those of Olsen et al.[7], who found that the pain
was predominantly located where the trauma had hit the
body (‘a local sign’); similarly, our patients who had been
exposed to falanga had more intense foot pain and larger
pain areas in the feet than those exposed to generalized
torture. However, comparing the two tortured groups
(generalized torture vs. falanga with generalized torture)
we had expected that there would be substantial local dif-
ferences, also in their sensory functions as examined by
QST. This was not the case. Rather, we found indications
that central, more than peripheral, mechanisms seem to
play a critical role in these pain conditions.
Regarding the use of QST in medico-legal matters,
such practice is not applicable, since the size of the ef-
fects of non-organic factors on the QST method is cur-
rently unresolved [30]. On the other hand, QST can assess
both large and small fiber function as illustrated in the in-
dividual profiles.
The high side-to-side correlations of all QST parameters
predict that short-term test-retest reliability within the
same day should be high. However, formal determination
of test-retest reliability over different time ranges of 1 day,
1 month or 1 year are not available [14].Study limitations
The patients were refugees with residence permits in
Denmark and had been referred by their general practi-
tioner to our specialized clinic, making our sample highly
selected, and thus it may not be representative of all tor-
ture victims.
With our traumatized patients, it was unfortunately
not possible to collect exact information on the extent
of torture. Attempts to retrieve such information may
produce intense anxiety and flash backs. Moreover, all
patients had been subjected to various forms of torture,
increasing the risk of brain injuries [31], which may con-
tribute to the pain reported. Torture victims are vul-
nerable, often forget and have difficulties in focusing
attention [32]. Using QST requires cooperation from the
patients and the dimensions of cognitive effects on QST
findings are not resolved [30,33]. Indeed, there are re-
cent indications that chronic widespread pain is associated
with lower cognitive processing speed [34]. Furthermore,
the need to use interpreters in a psychophysical study,especially in a population with high levels of anxiety and
depression, may present certain problems [35].
Since many of these patients have been imprisoned for
long time periods, it is important to distinguish the pre-
sent findings from those elicited by peripheral neuropathy,
whether from toxic, nutritional or infectious causes. How-
ever, the victims were carefully examined for such comor-
bidities during the medical assessment (see Methods) and
secondly, motor deficits, typical for severe polyneuropa-
thies, were never found among the included patients. Fur-
thermore, the combination often seen in our patients,
cutaneous hypoesthesia, normal nociceptive transmission
and deep mechanical hyperalgesia, is not typical for per-
ipheral neuropathies but has been reported without signs
of nerve injury in, for example, chronic regional pain syn-
drome [11; Appendix A in 27]. However it is difficult to
completely exclude the possibility of nerve injury here.
For patients with neuropathic pain, some of the QST
procedures may be briefly painful, for example the Wind-
up test. In our study design, we have considered this prob-
lem, and as is obvious from our methods, the patients
were always in control. In fact, we only had to discontinue
one of the sensory examination sessions due to pain.
Conclusion
In conclusion, by comparing QST data from the foot soles
of 32 torture victims in chronic pain to ethnically matched
healthy persons, we found hyperalgesia to deep mechanical
pressure in combination with cutaneous hypoesthesia to
non-nociceptive modalities to be a common sensory dis-
turbance. We interpret these findings as a sign of changes
in central sensory processing which may be the unifying
pathological mechanism of chronic pain in these persons.
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